Hands-on Tablet Development including principles of pre-formulation, formulation and process develop

Venue: County House

Location: Beckenham, BR3 4UF, United Kingdom

Event Date/Time: Mar 27, 2012 End Date/Time: Mar 29, 2012
Report as Spam


Learning outcomes:

Understanding of the relationship between Quality by Design, drug substance properties, formulation and process development
Practical experience of small scale tablet manufacture with direct knowledge of the relationship between formulation properties and tablet compressibility
Understanding of the roles of critical quality attributes, critical process parameters, and product control strategy in the application of the principles of QbD to formulation development

Who Should Attend?

Newcomers to tablet formulation development and manufacturing
Production operators who need a better understanding of their products and how they have been developed
Analytical and QC staff who would benefit from understanding the tablet development and production process
Experienced personnel in one area of product development who need a broader overview
Project team members needing a broader insight into formulation development including preclinical, clinical, and project management representatives
Regulatory staff who would benefit from brief practical experience of the processes for which they are compiling dossiers
Regulatory agency staff requiring practical experience

Course Programme

Day 1


Quality by Design (QbD) - ICH Q8-10
Material properties and their impact on processing
The role of excipients

Course Programme

8.30am Registration and coffee/tea

9.00am Welcome. Introductions. Plan for the day. Learning objectives for course

9.15am Introduction to Quality by Design - a new pharmaceutical manufacturing system. Regulatory guidance.

10.45am Coffee break

11.00am Drug substance properties and their impact on formulation development.

Part 1 - physico-chemical properties

12.45pm Lunch

1.45pm Drug substance properties and their impact on formulation development.

Part 1 - physico-chemical properties

3.00pm Tea break

3.15pm Practical - impact of material properties on bulk powder behaviour

Bulk density
Particle size and shape

4.45pm Wrap up

5.00pm Close

Day 2


Formulating good products

9.00am Consolidation. Plan for day. Learning objectives for day

9.15am Approaches to formulation development using QbD principles. Manufacturing Process selection - applicability of wet granulation/roller compaction/direct compression. Unit processes 1 - blending.

10.30am Coffee break

10.45am Unit processes 2 - granulation and drying. Factors affecting granulation and drying behaviour. Critical Process Parameters for these processes. Impact of powder properties on manufacturing behaviour

12.15pm Powder and granule characterisation - advanced techniques. Porosity, compressibility, surface area

12.45pm Lunch

1.30pm Granulation and drying practical

3.00pm Tea break

3.15pm Lubrication and compression practical

4.45pm Wrap up

5.00pm Close

Day 3


Process development and validation

9.00am Consolidation. Plan for day. Learning objectives for day

9.15am Principles of process development. FDA Process Validation Guidance 2011 and the impact of QbD

10.30am Coffee

10.45am Identifiying Critical Process Parameters and Critical Quality Attributes


12.45pm Lunch

1.45pm Practical - Direct compression products

Impact of excipient selection, grades, and processing on critical quality attributes

Content Uniformity

4.00pm Closing session with tea

5.00pm Depart


County House
221-241 Beckenham Road
United Kingdom

Additional Information

Tutors: Dr Michael Gamlen, Pharmaceutical Development Services Dr Dipankar Dey, PharmaTraining Services Ltd